Chembio Diagnostics, Inc. (CEMI)
(Delayed Data from NSDQ)
$7.11 USD
+0.01 (0.14%)
Updated May 3, 2019 04:13 PM ET
After-Market: $7.11 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
[CEMI]
Reports for Purchase
Showing records 21 - 40 ( 59 total )
Industry: Medical - Products
Industry: Medical - Products
Industry: Medical - Products
Industry: Medical - Products
Industry: Medical - Products
Industry: Medical - Products
Strong Sales and an Eye Outside of Infectious Diseases
Provider: The Benchmark Company
Analyst: WALD J
Industry: Medical - Products
Hit and a Miss--Looking to Commercialize in a Lumpy Environment
Provider: The Benchmark Company
Analyst: WALD J
Industry: Medical - Products
Industry: Medical - Products
Industry: Medical - Products
Industry: Medical - Products
Industry: Medical - Products
Industry: Medical - Products
Enters a Licensing, Distribution and Manufacturing Agreement to pursue the Asian Market
Provider: The Benchmark Company
Analyst: WALD J
Industry: Medical - Products
Chembio''s US Approval of HIV Test Delayed; Lowering Estimates
Provider: The Benchmark Company
Analyst: WALD J
Industry: Medical - Products
Industry: Medical - Products
Industry: Medical - Products
Industry: Medical - Products
Good Quarter; Lots Happening, a Lot of Opportunity on the Horizon
Provider: The Benchmark Company
Analyst: WALD J
Industry: Medical - Products
Assuming Coverage with a Speculative Buy Rating
Provider: The Benchmark Company